“…Overall, the literature demonstrates a similarly low donor‐site morbidity of the TMG flap in comparison to other commonly used free flaps such as the DIEP‐, and profunda artery perforator (PAP) flap (Cho et al, 2020; Siegwart, Bolbos, Tapking, et al, 2021; Tomouk et al, 2017). Although the donor‐site morbidity of the TMG flap has been extensively studied, we were unable to identify studies outlining strategies for a standardized management of various donor‐site complications (Craggs et al, 2014; Siegwart, Bolbos, Haug, et al, 2021; Siegwart, Bolbos, Tapking, et al, 2021; Siegwart, Fischer, Diehm, et al, 2021). This study aims to fill this gap and provides an overview of encountered donor‐site complications, associated risk factors and their management in a large series of TMG flaps.…”